the effect of digital storytelling on students' knowledge and attitude toward hpv and its vaccination

The Effect of Digital Storytelling-Based Education on Knowledge and Attitudes of Non-Medical Students Toward Human Papillomavirus (HPV) and Its Vaccination

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250522065849N1

Enrollment

210

Registered

2025-08-24

Start date

2025-09-12

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human papillomavirus. Papillomavirus as the cause of diseases classified elsewhere

Interventions

Intervention 1: Intervention Group 1: Digital Storytelling-Based Education

This group will participate in a two-week educational program consisting of four sessions (two sessions per week). Each session includes the presentation of a 5-minute educational video based on real-

Eligibility

Sex/Gender

All

Age

18 Years to 25 Years

Inclusion criteria

Inclusion criteria: being a student in a non-medical field at islamic azad university, karaj branch being enrolled in an undergraduate program at the time of study age between 18 and 25 years providing written informed consent to participate in the study Access to digital tools such as smartphones, laptops, or PCs to view the educational content (in the intervention group) ability to read, write, and understand persian

Exclusion criteria

Exclusion criteria: Prior HPV vaccination Known HPV infection or related conditions (e.g., genital warts/precancerous cervical lesions) Any formal/informal HPV or HPV-vaccine education within the past 6 months Severe psychiatric/neurological disorders impairing learning or questionnaire completion (self-report ) Inability to use digital tools due to severe sensory/physical limitations.

Design outcomes

Primary

Measure	Time frame
Knowledge level about Human Papillomavirus (HPV). Timepoint: Before the intervention, immediately after the intervention, one month after the intervention. Method of measurement: Knowledge and Attitude toward HPV questionnaire – Knowledge section (Pourkazemi et al., 2017), 36 items in three domains: general knowledge (13 items), cervical cancer risk factors (9 items), transmission routes and predisposing factors (14 items).;Attitude toward HPV. Timepoint: Before the intervention, immediately after the intervention, one month after the intervention. Method of measurement: Knowledge and Attitude toward HPV questionnaire – Attitude section (Pourkazemi et al., 2017), 9 items, 3-point Likert scale (agree=3, neutral=2, disagree=1).;Knowledge about HPV vaccine. Timepoint: Before the intervention, immediately after the intervention, one month after the intervention. Method of measurement: HPV Vaccine Knowledge Questionnaire (Mojahed et al., 2023), 10 items assessing prevention effect, side effects, appropriate age, and administration conditions.;Attitude toward HPV vaccination. Timepoint: Before the intervention, immediately after the intervention, one month after the intervention. Method of measurement: Attitude toward HPV Vaccination Questionnaire (McRee et al., 2010; Dempsey et al., 2014), 17 items, five domains: Access barriers (5), Harms (3), Effectiveness (3), Risk denial (3), Uncertainty (3).	—

Measure

Time frame

Knowledge level about Human Papillomavirus (HPV). Timepoint: Before the intervention, immediately after the intervention, one month after the intervention. Method of measurement: Knowledge and Attitude toward HPV questionnaire – Knowledge section (Pourkazemi et al., 2017), 36 items in three domains: general knowledge (13 items), cervical cancer risk factors (9 items), transmission routes and predisposing factors (14 items).;Attitude toward HPV. Timepoint: Before the intervention, immediately after the intervention, one month after the intervention. Method of measurement: Knowledge and Attitude toward HPV questionnaire – Attitude section (Pourkazemi et al., 2017), 9 items, 3-point Likert scale (agree=3, neutral=2, disagree=1).;Knowledge about HPV vaccine. Timepoint: Before the intervention, immediately after the intervention, one month after the intervention. Method of measurement: HPV Vaccine Knowledge Questionnaire (Mojahed et al., 2023), 10 items assessing prevention effect, side effects, appropriate age, and administration conditions.;Attitude toward HPV vaccination. Timepoint: Before the intervention, immediately after the intervention, one month after the intervention. Method of measurement: Attitude toward HPV Vaccination Questionnaire (McRee et al., 2010; Dempsey et al., 2014), 17 items, five domains: Access barriers (5), Harms (3), Effectiveness (3), Risk denial (3), Uncertainty (3).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSharareh Zeighami Mohammadi

Islamic Azad University

zeighamimohammadi@iau.ac.ir+98 26 3418 2570

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026